Indian Pharma Stocks Outlook: Why Small-Cap Players Could Lead The Next Rally

India's pharmaceutical sector continues to offer compelling long-term opportunities, particularly in innovation-led businesses. Abhay Agarwal, Founder and Fund Manager, Piper Serica, says the fund remains heavily invested in pharma and healthcare, with nearly 30% of its portfolio allocated to the sector. He believes smaller companies focused on innovative formulations, CDMO services and advanced manufacturing are better positioned than traditional generic drug makers. According to Agarwal, several companies are targeting strong growth over the next few years as they expand in global markets. Watch the full discussion for his top insights on India's evolving pharma investment story.